{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:21:46Z","timestamp":1789435306417,"version":"build-2803163510"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1287,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1111\/j.1365-2133.2011.10712.x","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T17:12:24Z","timestamp":1320253944000},"page":"474-482","source":"Crossref","is-referenced-by-count":55,"title":["Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy"],"prefix":"10.1093","volume":"166","author":[{"given":"H.L.","family":"H\u00e9bert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/0001555562229236","article-title":"Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution","volume":"62","author":"Brandrup","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.32.3.181","article-title":"Familial occurrence of psoriatic arthritis","volume":"32","author":"Moll","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/rheumatology\/keh589","article-title":"Recurrence risk for psoriasis and psoriatic arthritis within sibships","volume":"44","author":"Myers","year":"2005","journal-title":"Rheumatology"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM197210122871504","article-title":"Disturbance of HL-A antigen frequency in psoriasis","volume":"287","author":"White","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM197210122871503","article-title":"Histocompatibility (HL-A) antigens associated with psoriasis","volume":"287","author":"Russell","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB7|cit7","first-page":"301","article-title":"HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbations after respiratory infections and occurrence of arthritis","volume":"7","author":"Karvonen","year":"1975","journal-title":"Ann Clin Res"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","article-title":"Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris","volume":"13","author":"Henseler","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI109903","article-title":"Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex","volume":"66","author":"Murray","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00447371","article-title":"HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset","volume":"262","author":"Brenner","year":"1978","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","article-title":"Psoriasis and HLA-Cw6","volume":"102","author":"Tiilikainen","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"e1000041","DOI":"10.1371\/journal.pgen.1000041","article-title":"A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci","volume":"4","author":"Liu","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","article-title":"Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis","volume":"42","author":"Huffmeier","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/hmg\/ddn091","article-title":"Identification of ZNF313\/RNF114 as a novel psoriasis susceptibility gene","volume":"17","author":"Capon","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/6.5.813","article-title":"Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis","volume":"6","author":"Trembath","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/hmg\/8.12.2165","article-title":"Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111\u2003kb segment telomeric to the HLA-C gene","volume":"8","author":"Oka","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/hmg\/8.6.1135","article-title":"Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis","volume":"8","author":"Tazi Ahnini","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","article-title":"Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis","volume":"120","author":"Asumalahti","year":"2003","journal-title":"J Investig Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.0022-202X.2004.23511.x","article-title":"The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis","volume":"124","author":"Allen","year":"2005","journal-title":"J Investig Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.690","article-title":"Association analyses identify six new psoriasis susceptibility loci in the Chinese population","volume":"42","author":"Sun","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/sj.jid.5701140","article-title":"Polymorphisms in the IL-12\u03b2 and IL-23R genes are associated with psoriasis of early onset in a UK cohort","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.2007.48","article-title":"Psoriasis is associated with increased beta-defensin genomic copy number","volume":"40","author":"Hollox","year":"2008","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(86)92161-6","article-title":"Effect of interferon on psoriasis","volume":"2","author":"Harrison","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000248777","article-title":"Parenteral interferon-alpha treatment of psoriasis","volume":"175","author":"Neumann","year":"1987","journal-title":"Dermatalogica"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0140-6736(86)91502-3","article-title":"Psoriasis and alpha-interferon","volume":"1","author":"Quesada","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.192.2.219","article-title":"Natural interferon alpha\/beta-producing cells link innate and adaptive immunity","volume":"192","author":"Kadowaki","year":"2000","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/ard.2010.130575","article-title":"Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis","volume":"69","author":"Bowes","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1002\/art.24128","article-title":"Investigation of association of the IL12B and IL23R genes with psoriatic arthritis","volume":"58","author":"Filer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2011.150102","article-title":"Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1136\/ard.2004.030775","article-title":"Genetic epidemiology of psoriasis and psoriatic arthritis","volume":"64","author":"Rahman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.1780380619","article-title":"The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model","volume":"38","author":"Gladman","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB43|cit43","first-page":"660","article-title":"A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2\/IL21","volume":"164","author":"Warren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard.2010.147421","article-title":"IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients","volume":"70","author":"Eder","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/ard.2010.143123","article-title":"Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"e1000337","DOI":"10.1371\/journal.pgen.1000337","article-title":"Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers","volume":"5","author":"Jakobsdottir","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrg2516","article-title":"Beyond odds ratios - communicating disease risk based on genetic profiles","volume":"10","author":"Kraft","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03256357","article-title":"The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis","volume":"14","author":"Ryan","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2005.06880.x","article-title":"The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis","volume":"153","author":"Warren","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2230.2008.02976.x","article-title":"Methotrexate for psoriasis in the era of biological therapy","volume":"33","author":"Warren","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/jid.2008.16","article-title":"Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis","volume":"128","author":"Warren","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2133.2008.08898.x","article-title":"Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms","volume":"160","author":"Warren","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/sj.jid.5700808","article-title":"Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis","volume":"127","author":"Campalani","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB54|cit54","first-page":"2898","article-title":"A novel single nucleotide polymorphism within the 5\u2032 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity","volume":"63","author":"Mandola","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.tpj.6500401","article-title":"A novel G\/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele","volume":"6","author":"Gusella","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3899\/jrheum.091311","article-title":"Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis","volume":"37","author":"Chandran","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB57|cit57","first-page":"728","article-title":"Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis","volume":"28","author":"Xiao","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.2005.06950.x","article-title":"Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin","volume":"154","author":"Campalani","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB61|cit61","first-page":"1391","article-title":"Preliminary pharmacogenetic assessment of tumour necrosis factor (TNF) polymorphisms in psoriasis: response to anti-TNF and systemic therapies","volume":"159","author":"Tejasvi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kel175","article-title":"The \u2212308 tumour necrosis factor-\u03b1-gene polymorphism predicts therapeutic response to TNF\u03b1-blockers in rheumatoid arthritis and spondyloarthritis patients","volume":"46","author":"Seitz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/hmg\/ddn245","article-title":"Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis","volume":"17","author":"Maxwell","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB64|cit64","first-page":"1392","article-title":"HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis","volume":"159","author":"Costanzo","year":"2008","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2011.10712.x-BIB65|cit65","first-page":"28","article-title":"A study to examine if the HLA-Cw*0602 allele is a predictor of response to TNF-\u03b1 inhibitors in the treatment of psoriasis","volume":"161","author":"Ryan","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis - oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0190-9622(93)70101-X","article-title":"Alcohol intake and treatment responsiveness of psoriasis: a prospective study","volume":"28","author":"Gupta","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB68|cit68","first-page":"1","article-title":"Stress as an influencing factor in psoriasis","volume":"16","author":"Heller","year":"2011","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/j.1365-2133.2011.10712.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.27457","article-title":"Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy","volume":"62","author":"Cui","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10712.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10712.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T10:33:06Z","timestamp":1713090786000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/3\/474\/6613697"}},"subtitle":["Psoriasis and psoriatic arthritis: genetic and pharmacogenetic update"],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10712.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}